NDAINJECTIONINJECTABLE
Lifecycle
Pre-Launch
Clinical Trials
3
Data completeness
3/8 — Basic
HEPARIN SODIUM (heparin sodium) by Bristol Myers Squibb is protein, antithrombin iii, to induce a conformational change, which markedly enhances the serine protease activity of antithrombin ii, thereby inhibiting the activated coagulation factors involved in the closing sequence, particularly xa and iia. Approved for venous thromboembolism, deep venous thrombosis, stemi and 5 more indications.
Drug data last refreshed 2w ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Heparin Sodium is an injectable anticoagulant that works by enhancing antithrombin III activity to inhibit activated coagulation factors Xa and IIa, preventing thrombus formation. It is indicated for venous thromboembolism, deep venous thrombosis, acute coronary syndromes (STEMI, primary PCI), COVID-19 thromboprophylaxis, and cerebrovascular conditions. Unlike fibrinolytic agents, heparin prevents clot formation but does not dissolve existing clots.
Pre-Launch
Pre-launch status suggests building commercial infrastructure with opportunities for launch marketing, field team expansion, and clinical education roles at Bristol Myers Squibb.
Mechanism of Action
protein, antithrombin III, to induce a conformational change, which markedly enhances the serine protease activity of Antithrombin II, thereby inhibiting the activated coagulation factors involved in the closing sequence, particularly Xa and IIa. Small amounts of heparin inhibit Factor Xa, and…
Worked on HEPARIN SODIUM at Bristol Myers Squibb? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.